We'll be right back

The portal is under maintenance. Signed-in users can continue to the app.

Sign In

X-System Market Access Portal

Pricing, prevalence and reimbursement analysis for drug-resistant epilepsy — every NHS Integrated Care Board and all 27 EU member states, with every figure traceable to a published source.

Sign In Request Access
~150,000
drug-resistant epilepsy patients across England's 42 ICBs
~1.06M
drug-resistant patients across the EU27
28
markets analysed: UK plus all 27 EU member states